Literature DB >> 8030983

The three-dimensional structure of human interleukin-5 at 2.4-angstroms resolution: implication for the structures of other cytokines.

T N Wells1, P Graber, A E Proudfoot, C Y Arod, S R Jordan, M H Lambert, A M Hassel, M V Milburn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8030983     DOI： 10.1111/j.1749-6632.1994.tb39796.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.

Authors:  A E Proudfoot; S C Brown; P Graber; F Talabot; C Y Arod; M C Peitsch; M Banks; M McKinnon; R Solari; T N Wells
Journal:  J Protein Chem       Date:  1996-07

Review 2.  Mepolizumab in eosinophilic disorders.

Authors:  J Pablo Abonia; Philip E Putnam
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

Review 3.  Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Sofia Taddei; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Chronic Dis       Date:  2016-08-11       Impact factor: 5.091

4.  Identification of interleukin genes in Pogona vitticeps using a de novo transcriptome assembly from RNA-seq data.

Authors:  Alexandra Livernois; Kristine Hardy; Renae Domaschenz; Alexie Papanicolaou; Arthur Georges; Stephen D Sarre; Sudha Rao; Tariq Ezaz; Janine E Deakin
Journal:  Immunogenetics       Date:  2016-06-02       Impact factor: 2.846

Review 5.  Along the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to Mammals.

Authors:  Takuya Yamaguchi; Fumio Takizawa; Uwe Fischer; Johannes M Dijkstra
Journal:  Biology (Basel)       Date:  2015-11-17

Review 6.  Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Sofia Taddei; Luigi Zucchi
Journal:  J Asthma Allergy       Date:  2015-10-08

Review 7.  The clinical profile of benralizumab in the management of severe eosinophilic asthma.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Respir Dis       Date:  2016-09-09       Impact factor: 4.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.